![Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease | Scientific Reports Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-79207-z/MediaObjects/41598_2020_79207_Fig1_HTML.png)
Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease | Scientific Reports
![PDF) Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission PDF) Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission](https://i1.rgstatic.net/publication/283794693_Long-Term_Benefit_of_Mesalamine_Granules_for_Patients_Who_Achieved_Corticosteroid-Induced_Ulcerative_Colitis_Remission/links/568c258508ae153299b6435a/largepreview.png)
PDF) Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission
![Mesalazine and inflammatory bowel disease – From well-established therapies to progress beyond the state of the art - ScienceDirect Mesalazine and inflammatory bowel disease – From well-established therapies to progress beyond the state of the art - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0939641121002010-ga1.jpg)
Mesalazine and inflammatory bowel disease – From well-established therapies to progress beyond the state of the art - ScienceDirect
![JCM | Free Full-Text | Switching between Three Types of Mesalazine Formulation and Sulfasalazine in Patients with Active Ulcerative Colitis Who Have Already Received High-Dose Treatment with These Agents JCM | Free Full-Text | Switching between Three Types of Mesalazine Formulation and Sulfasalazine in Patients with Active Ulcerative Colitis Who Have Already Received High-Dose Treatment with These Agents](https://pub.mdpi-res.com/jcm/jcm-08-02109/article_deploy/html/images/jcm-08-02109-g001-550.jpg?1577705161)
JCM | Free Full-Text | Switching between Three Types of Mesalazine Formulation and Sulfasalazine in Patients with Active Ulcerative Colitis Who Have Already Received High-Dose Treatment with These Agents
![Exacerbation of Bloody Diarrhea as a Side Effect of Mesalamine Treatment of Active Ulcerative Colitis – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on Exacerbation of Bloody Diarrhea as a Side Effect of Mesalamine Treatment of Active Ulcerative Colitis – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on](https://cyberleninka.org/viewer_images/573117/f/1.png)
Exacerbation of Bloody Diarrhea as a Side Effect of Mesalamine Treatment of Active Ulcerative Colitis – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on
![Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines | Gut Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines | Gut](https://gut.bmj.com/content/gutjnl/51/4/536/F2.large.jpg?width=800&height=600&carousel=1)
Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines | Gut
![PDF) Long-term efficacy and safety of once-daily mesalazine granules for the treatment of active ulcerative colitis PDF) Long-term efficacy and safety of once-daily mesalazine granules for the treatment of active ulcerative colitis](https://i1.rgstatic.net/publication/266617480_Long-term_efficacy_and_safety_of_once-daily_mesalazine_granules_for_the_treatment_of_active_ulcerative_colitis/links/5435b4a10cf2dc341db2b655/largepreview.png)
PDF) Long-term efficacy and safety of once-daily mesalazine granules for the treatment of active ulcerative colitis
Full article: Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX® mesalamine
![Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines | Gut Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines | Gut](https://gut.bmj.com/content/gutjnl/51/4/536/F1.large.jpg?width=800&height=600&carousel=1)